Bonraybio Co., Ltd. (TWSE: 6955)
Health Care · Biotechnology · TW
NT$123.00
+0.82% today · -26.9% 1Y
Bonraybio Co., Ltd. (TWSE: 6955) operates in the Biotechnology industry within the Health Care sector. The company is valued at $95.34M.
Over the last twelve months the share price has lost 26.9%, trading between 109.00 and 177.00.
Tweenvest scores Bonraybio Co., Ltd. across four factors: quality 74/100, value 73/100, dividend 48/100. Its strongest factor is quality.
6955 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $95.34M
- Revenue (TTM)
- $10.44M
- P/E
- 28.41
- EPS
- 4.33
- Dividend yield
- 1.22%
- Beta (5Y)
- 0.07
- 52-week high
- NT$177.00
- 52-week low
- NT$109.00
- Avg volume (3M)
- —
- Shares outstanding
- 24.80M
- Employees
- —
- Next earnings
- —
About Bonraybio Co., Ltd.
Bonraybio Co., Ltd., a development stage company, manufactures medical instruments and solutions for the male infertility market. The company provides LensHooke X12 PRO semen analysis systems; and LensHooke X1 PRO semen quality analyzers. It also provides consumables, such as CS3 semen test slides; CA0/CA1 sperm separation solutions; and CS1 semen test cassettes. In addition, the company provides X QC Reticles, X QC video tools, and X QC beads; sperm DNA fragmentation test kits; and S10 data consolidation software. Bonraybio Co., Ltd. was founded in 2015 and is based in Taichung, Taiwan.
- ISIN
- TW0006955008
- Founded
- 2015
- Listed since
- Dec 6, 2024
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $266.13 | +0.61% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $443.85 | +0.00% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $147.79 | +0.72% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $553.94 | +1.16% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $834.55 | +0.73% |
| argenx SEENXTBR: ARGX | $63.06B | €879.20 | +1.74% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $157.42 | +13.34% |
Figures last refreshed Aug 18, 2026.